IL17A and lung cancer: With respect to the role of the inflammatory cytokines IL-17 signaling pathway, the mounting data showed that IL-17 positively correlated with the tumor proliferation, progression, and metastasis in various malignancies such as prostate cancer (56), colorectal cancer (57), lung cancer (58), and HCC (59).